Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

ASAH2B Inhibitors

ASAH2B inhibitors are a class of chemical compounds designed to target and modulate the activity of the ASAH2B enzyme, also known as acid ceramidase-like protein 2. ASAH2B is an enzyme that plays a key role in the metabolism of sphingolipids, particularly in the hydrolysis of ceramides into sphingosine and free fatty acids. Ceramides are essential components of cellular membranes and are also involved in various cellular signaling pathways that regulate processes such as cell growth, differentiation, and apoptosis. By inhibiting ASAH2B, these compounds disrupt the normal breakdown of ceramides, leading to alterations in sphingolipid metabolism and associated cellular processes. ASAH2B inhibitors are therefore crucial for studying the role of this enzyme in cellular homeostasis and lipid metabolism.

The development of ASAH2B inhibitors involves a multi-faceted approach that includes understanding the enzyme's structure, its catalytic mechanism, and the identification of potential binding sites for inhibitors. Structural biology techniques such as X-ray crystallography and cryo-electron microscopy are employed to determine the three-dimensional configuration of ASAH2B, revealing the organization of its active site and other critical regions involved in substrate binding and catalysis. This structural information is essential for the rational design of inhibitors that can specifically target these sites, effectively blocking the enzyme's activity. Computational methods, including molecular docking and virtual screening, are often used to identify and optimize chemical compounds that can bind to ASAH2B with high affinity. Once potential inhibitors are identified, they are synthesized and subjected to biochemical assays to evaluate their effectiveness in inhibiting ASAH2B activity. These assays measure parameters such as binding affinity, inhibitory concentration, and the effects on ceramide metabolism. Through these studies, researchers refine the inhibitors to enhance their potency, selectivity, and stability, developing them into powerful tools for probing the biological functions of ASAH2B and its role in the broader context of sphingolipid metabolism and cellular regulation.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Fumonisin B1

116355-83-0sc-201395
sc-201395A
1 mg
5 mg
$200.00
$680.00
18
(1)

Fumonisin B1 inhibits ceramide synthase, potentially leading to reduced substrate availability for ASAH2B.

Myriocin (ISP-1)

35891-70-4sc-201397
10 mg
$150.00
8
(2)

Myriocin, a potent inhibitor of serine palmitoyltransferase, can indirectly affect ASAH2B activity by altering sphingolipid biosynthesis.

β-Chloro-L-alanine

2731-73-9sc-291972
sc-291972A
1 g
5 g
$138.00
$581.00
1
(0)

β-Chloro-L-alanine inhibits alanine aminotransferase, potentially affecting ASAH2B by altering amino acid metabolism linked to sphingolipid metabolism.

GW4869

6823-69-4sc-218578
sc-218578A
5 mg
25 mg
$203.00
$611.00
24
(3)

GW4869, a non-competitive inhibitor of neutral sphingomyelinase, might influence ASAH2B activity indirectly by altering ceramide levels.

Tipifarnib

192185-72-1sc-364637
10 mg
$720.00
(0)

Tipifarnib, a farnesyltransferase inhibitor, may affect ASAH2B indirectly by altering protein prenylation and membrane association.

D-Cycloserine

68-41-7sc-221470
sc-221470A
sc-221470B
sc-221470C
200 mg
1 g
5 g
25 g
$28.00
$77.00
$142.00
$530.00
4
(0)

L-Cycloserine, by inhibiting serine racemase, could indirectly influence ASAH2B activity via amino acid metabolism pathways.

SKI II

312636-16-1sc-204286
sc-204286A
10 mg
50 mg
$96.00
$400.00
3
(2)

SKI-II, a sphingosine kinase inhibitor, can raise sphingosine levels, potentially leading to feedback inhibition of ASAH2B.